[¹¹C]Choline uptake with PET/CT for the initial diagnosis of prostate cancer: relation to PSA levels, tumour stage and anti-androgenic therapy

By Reske Sven  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 35, Iss. 9, 2008-09 ,pp. : 1740-1741

Springer Publishing Company

Access to resources Recommend Favorite

TRUS–MRI image registration: a paradigm shift in the diagnosis of significant prostate cancer

By Cornud F.   Brolis L.   Delongchamps N.   Portalez D.   Malavaud B.   Renard-Penna R.   Mozer P.  

Abdominal Imaging, Vol. 38, Iss. 6, 2013-12 ,pp. : 1447-1463

Springer Publishing Company

Access to resources Recommend Favorite

Relative influence of Gleason score and pretreatment PSA in predicting survival following brachytherapy for prostate cancer

By Beyer D.C.   Thomas T.   Hilbe J.   Swenson V.  

Brachytherapy, Vol. 2, Iss. 2, 2003-06 ,pp. : 77-84

Elsevier

Access to resources Recommend Favorite

[¹⁸F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients

By Cimitan Marino   Bortolus Roberto   Morassut Sandro   Canzonieri Vincenzo   Garbeglio Antonio   Baresic Tanja   Borsatti Eugenio   Drigo Annalisa   Trovò Mauro  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 33, Iss. 12, 2006-12 ,pp. : 1387-1398

Springer Publishing Company

Access to resources Recommend Favorite

Prostate-specific antigen (PSA) velocity and benign prostate hypertrophy predict for PSA spikes following prostate brachytherapy

By Merrick G.S.   Butler W.M.   Wallner K.E.   Lief J.H.   Hinerman-Mulroy A.   Galbreath R.W.  

Brachytherapy, Vol. 2, Iss. 3, 2003-09 ,pp. : 181-188

Elsevier

Access to resources Recommend Favorite